Dana-Farber Cancer Institute
S

Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Breast Cancer

By Dana-Farber Cancer Institute FEATURING Sara Tolaney
By Dana-Farber Cancer Institute FEATURING Sara Tolaney
5,515 views
September 24, 2019
Comments 1
Login to view comments. Click here to Login

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Related Videos

25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

4.3K views
12:14

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

2.2K views
06:51

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

546 views
15:57

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

618 views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

842 views
38:49

ESMO 2024 Summary: eBC Panel Discussion on Key Studies - KEYNOTE-522…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

586 views
20:32

ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Bre…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

556 views
09:12

ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, …

2024 ESMO Annual Meeting Insights Hub

V. Kaklamani

539 views
20:25

ESMO 2024 Summary: Highlights in mBC

2024 ESMO Annual Meeting Insights Hub

G. Bianchini

533 views
29:24

ESMO 2024 Summary: Breast Cancer Highlights - AURORA Program, DAISY …

2024 ESMO Annual Meeting Insights Hub

C. Sotiriou

543 views
11:58

ESMO 2024 Summary: Tailoring Therapy in TNBC and Beyond

2024 ESMO Annual Meeting Insights Hub

L. Carey

371 views
26:06

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

640 views
12:07

ESMO 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

557 views
04:03

Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in m…

Fernanda Mosele

371 views
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views
33:44

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

930 views
11:54

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

462 views
19:15

Benefits of Oral Formulations in HR+/HER2- mBC: Reducing Time Toxici…

Priya Tiwari

494 views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2.0K views
04:06

ESMO 2024 Insights: TroFuse-010 Trial - Sacituzumab Tirumotecan ± Pe…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney

262 views
AUTOPLAY